These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors. Cunha-Reis D; Ribeiro JA; Sebastião AM Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995 [TBL] [Abstract][Full Text] [Related]
3. Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors. Cunha-Reis D; Aidil-Carvalho Mde F; Ribeiro JA Hippocampus; 2014 Nov; 24(11):1353-63. PubMed ID: 24935659 [TBL] [Abstract][Full Text] [Related]
4. VPAC2 receptor activation mediates VIP enhancement of population spikes in the CA1 area of the hippocampus. Cunha-Reis D; Ribeiro JA; Sebastião AM Ann N Y Acad Sci; 2006 Jul; 1070():210-4. PubMed ID: 16888168 [TBL] [Abstract][Full Text] [Related]
5. A1 and A2A receptor activation by endogenous adenosine is required for VIP enhancement of K+ -evoked [3H]-GABA release from rat hippocampal nerve terminals. Cunha-Reis D; Ribeiro JA; Sebastião AM Neurosci Lett; 2008 Jan; 430(3):207-12. PubMed ID: 18054436 [TBL] [Abstract][Full Text] [Related]
7. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis. Yadav M; Huang MC; Goetzl EJ Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288 [TBL] [Abstract][Full Text] [Related]
8. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production. Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701 [TBL] [Abstract][Full Text] [Related]
9. Alterations in the relative abundance of the vasoactive intestinal peptide receptors (VPAC1 and VPAC2) and functions in uterine contractility during inflammation. Palus K; Całka J; Jana B Anim Reprod Sci; 2021 Feb; 225():106680. PubMed ID: 33388613 [TBL] [Abstract][Full Text] [Related]
10. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland. Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629 [TBL] [Abstract][Full Text] [Related]
11. Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors. Langer I; Latek D Front Endocrinol (Lausanne); 2021; 12():711906. PubMed ID: 34867774 [TBL] [Abstract][Full Text] [Related]
12. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects. Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439 [TBL] [Abstract][Full Text] [Related]
13. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons. Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242 [TBL] [Abstract][Full Text] [Related]
14. Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries. Grant S; Lutz EM; McPhaden AR; Wadsworth RM J Cereb Blood Flow Metab; 2006 Jan; 26(1):58-67. PubMed ID: 15959462 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of vasoactive intestinal peptide-elicited coronary vasodilation in the isolated perfused rat heart. Sawmiller DR; Ashtari M; Urueta H; Leschinsky M; Henning RJ Neuropeptides; 2006 Oct; 40(5):349-55. PubMed ID: 17030371 [TBL] [Abstract][Full Text] [Related]
16. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents. Fizanne L; Sigaudo-Roussel D; Saumet JL; Fromy B J Physiol; 2004 Jan; 554(Pt 2):519-28. PubMed ID: 14578481 [TBL] [Abstract][Full Text] [Related]
17. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L; Ahrén B; Edgren G; Degerman E Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088 [TBL] [Abstract][Full Text] [Related]
18. Role of VPAC2 receptor in monocrotaline-induced pulmonary hypertension in rats. Koga M; Mizuno Y; Watanabe I; Kawakami H; Goto T J Appl Physiol (1985); 2014 Aug; 117(4):383-91. PubMed ID: 24947028 [TBL] [Abstract][Full Text] [Related]